Search the Newsreel

Alignment Healthcare (NASDAQ: ALHC) raises 2026 outlook after Q2 revenue jump

Alignment Healthcare (ALHC) reported strong Q2 2026 results, with total revenue increasing by 31.6% year-over-year to $1,335.6 million and health plan membership growing by 31.5% to approximately 294,100. The company surpassed its guidance across key metrics, achieving adjusted EBITDA of $68.1 million and net …

Alignment Healthcare, Inc. Quarterly Earnings Report

Alignment Healthcare, Inc. (ALHC) reported its quarterly earnings, with a net income of $36.56 million for the quarter ended June 30, 2026, and $47.98 million for the six months ended June 30, 2026. The company experienced significant growth in Health Plan membership, reaching 294,100 …

Alignment Healthcare: Q2 Earnings Snapshot

Alignment Healthcare (ALHC) reported strong second-quarter results, with earnings of $36.6 million, or 17 cents per share, surpassing Wall Street expectations of 13 cents per share. The Medicare Advantage insurer also exceeded revenue forecasts, posting $1.34 billion against an expected $1.31 billion. Despite a …

Alignment Healthcare, Inc. (ALHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alignment Healthcare, Inc. (ALHC) following allegations of accounting irregularities that "artificially inflated" the company's financial results. A whistleblower complaint suggests "millions of dollars in operating expenses had been systematically misclassified as capital expenditures," leading …

Compared to Estimates, Alignment Healthcare (ALHC) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Alignment Healthcare (ALHC) reported revenue of $1.34 billion, up 31.6% over the same period last year. EPS came in at $0.17, compared to $0.07 in the year-ago quarter. The reported revenue represents a surprise of +1.97% over the …

Alignment Healthcare (ALHC) Beats Q2 Earnings and Revenue Estimates

Alignment Healthcare (ALHC) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Alignment Healthcare, Inc. (ALHC) Q2 2026 Earnings

Alignment Healthcare, Inc. (ALHC) reported its Q2 2026 earnings, missing EPS estimates by 16% with $0.17 against an estimated $0.20, despite a 48% jump in adjusted EBITDA. The company beat revenue expectations by 2%, reaching $1.34 billion, driven by a 31.5% membership surge. ALHC …

Alignment Healthcare (NASDAQ:ALHC) Beats Q2 CY2026 Sales Expectations But Stock Drops

Alignment Healthcare (NASDAQ:ALHC) Beats Q2 CY2026 Sales Expectations But Stock Drops Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 31.6% year on year to $1.34 billion. The company expects next quarter's revenue to …

Lowey Dannenberg, P.C. is Investigating Alignment

Lowey Dannenberg, P.C. is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential federal securities law violations. This investigation follows a whistleblower lawsuit alleging that Alignment manipulated its finances by misclassifying operating expenses as capital expenditures to inflate its adjusted EBITDA and boost its stock …

Alignment Healthcare Turns Profit As Insurer Gets Handle On Costs

Alignment Healthcare reported a significant increase in its second-quarter net income, more than doubling to $36.6 million, primarily due to lower medical costs for its Medicare Advantage members. The company's medical benefit ratio improved to 86%, marking a second consecutive quarter of decline in …

Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics

Alignment Healthcare, Inc. (NASDAQ: ALHC) announced strong second-quarter 2026 financial results, exceeding guidance across all key metrics. The company reported $1.3 billion in total revenue, a 31.6% year-over-year increase, and grew Medicare Advantage membership by 31.5% to approximately 294,100 members. Consequently, Alignment Healthcare raised …

PACS or ALHC: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with PACS Group, Inc. (PACS) and Alignment Healthcare (ALHC). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. We have found that the …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Alignment Healthcare, Inc. (ALHC) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alignment Healthcare, Inc. (ALHC) following allegations of accounting irregularities that artificially inflated financial results. A whistleblower complaint suggests "millions of dollars in operating expenses had been systematically misclassified as capital expenditures," leading to a …

Alignment Healthcare LLC earnings beat by $0.04, revenue fell short of estimates

ALHC|Alignment Healthcare Inc|Price:18.290|Chg%:-0.140

Alignment Healthcare Inc (ALHC) exhibits strong fundamentals and high growth potential, despite recent weak stock market performance. The company's valuation is considered fair, ranking 5th in its industry, with high institutional ownership and multiple analyst "Buy" ratings. Its stock price is currently trading sideways, …

Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Learn More About the Investigation of Potential Securities Law Violations

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare …

Bronstein, Gewirtz & Grossman, LLC Encourages Alignment Healthcare, Inc. (ALHC) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential securities claims on behalf of purchasers of Alignment Healthcare, Inc. (ALHC). This investigation follows allegations from a former executive of "accounting irregularities" and the artificial inflation of financial results, including "Adjusted EBITDA," which led to a …

Alignment Healthcare (ALHC) Reports Earnings Tomorrow: What To Expect

Alignment Healthcare (ALHC) is set to announce its earnings this Thursday afternoon. The company exceeded revenue expectations last quarter, reporting $1.24 billion, a 33.3% year-on-year increase, and analysts are projecting a 29% revenue growth for the upcoming quarter. Despite a positive sentiment in the …

Alignment Healthcare Inc (ALHC) Cash Flow

This article provides a detailed cash flow statement for Alignment Healthcare Inc (ALHC), presenting quarterly and annual figures for operating, investing, and financing activities. It includes key financial metrics such as net income from continuing operations, capital expenditures, and free cash flow, along with …

Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz has initiated an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) regarding potential federal securities law violations. This follows a whistleblower lawsuit filed by a former executive, alleging financial manipulation to inflate the company's stock price and executive …

ALHC INVESTOR ALERT: HBSS Launches Investigation into

Hagens Berman Sobol Shapiro LLP has launched an investigation into Alignment Healthcare, Inc. (ALHC) following whistleblower allegations of financial manipulation. A former executive claims the company misclassified operating expenses as capital expenditures to inflate adjusted EBITDA for 2024 and 2025, artificially boosting its stock …

ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation

SAN FRANCISCO, July 28, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman (HBSS) is investigating potential violations of U.S. securities laws by Alignment Healthcare, Inc. (NASDAQ: ALHC) following reports of a whistleblower lawsuit alleging systemic financial manipulation. SUBMIT YOUR ALHC INVESTMENT LOSSES …

Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Securities Law Violations - Investors Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (ALHC) for potential securities law violations after a whistleblower alleged accounting irregularities that artificially inflated the company's financial results. This follows news on July 8, 2026, where the stock price fell 16.7% after allegations …

BlackRock (ALHC) discloses 18.7M Alignment Healthcare shares with sole voting power

BlackRock, Inc. has filed a Schedule 13G/A, disclosing beneficial ownership of 18,719,986 shares of Alignment Healthcare, Inc. (ALHC) common stock, which represents a 9.1% stake. BlackRock holds sole voting power over 18,431,099 shares and sole dispositive power over all 18,719,986 shares. No single underlying …

ALHC INVESTOR ALERT: Holzer & Holzer, LLC Announces Investigation of Alignment Healthcare, Inc.

Holzer & Holzer, LLC has launched an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) to determine if the company violated federal securities laws. This investigation follows a lawsuit filed by a former executive alleging that Alignment materially misclassified millions in operating expenses as capital …

Alignment Healthcare (ALHC) Slides as Investors Digest Index Addition and Leadership Shake-up

Alignment Healthcare (ALHC) experienced a stock decline following news of its inclusion in the S&P SmallCap 600 index and a leadership change. The company announced that CEO John Kao will transition to Executive Chairman, with Ken Goulet taking over as CEO. Investors are likely …

ALHC Investors Have Opportunity to Join Alignment Healthcare, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) on behalf of investors following allegations of accounting irregularities. A whistleblower lawsuit filed on July 8, 2026, claims the company misclassified operating expenses in 2024 and 2025 to inflate its EBITDA, leading to …

Alignment Healthcare (ALHC) Stock Looks Below Fair Value After Legal Questions

Alignment Healthcare (ALHC) stock has seen a significant 237.9% return over three years but is currently screening as undervalued in Simply Wall St's checks. The company faces fresh legal and regulatory questions, including whistleblower allegations and a lawsuit concerning Medicare Advantage star ratings, which …

Alignment Healthcare (ALHC) Stock Looks Reasonable On Its 238% Three Year Run

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Alignment Healthcare stock has surged over the past three years, yet the recent pullback and a strong overall value score raise a clear …

ETFs Investing in Alignment Healthcare, Inc. Stocks

This article lists various ETFs that include Alignment Healthcare, Inc. (ALHC) stocks in their portfolios. It provides a detailed table with each ETF's market value, weight of ALHC stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, …

Alignment Healthcare Under Investigation for Fraud Claims

Alignment Healthcare (ALHC) is under investigation by Pomerantz LLP and other firms following whistleblower allegations of accounting irregularities that artificially inflated the company's Adjusted EBITDA. A former executive filed a complaint on July 8, 2026, claiming financial manipulation. This news caused Alignment's stock price …

Kaplan Fox Urges Investors of Alignment Healthcare, Inc. (ALHC) to Contact the Firm Regarding Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) after a former executive filed a whistleblower complaint alleging accounting irregularities and inflated financial results. The complaint claims operating expenses were misclassified as capital expenditures, leading to a …

3 Healthcare Stocks with Competitive Advantages

3 Healthcare Stocks with Competitive Advantages From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry's returns lately - over the past six …

ALHC6247090 Bond Profile — Key Metrics

This article provides key financial metrics for the ALHC6247090 corporate bond issued by Alignment Healthcare, Inc. It details the bond's coupon rate, maturity date, issue date, outstanding amount, and face value. The company, founded by John E. Kao in 2013, focuses on offering consumer-centric …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alignment Healthcare, Inc. (ALHC) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Alignment Healthcare, Inc. (ALHC) following allegations from a whistleblower lawsuit. The lawsuit claims that Alignment manipulated its finances by misclassifying operating expenses as capital expenditures, artificially inflating its adjusted EBITDA. This news led to …

Alignment Healthcare Inc (ALHC) Shares Fall 3.4% -- What GF Score of 78 Tells Investors

Alignment Healthcare Inc (ALHC) shares recently fell 3.4% to $20.77, trading above its GF Value™ estimate of $19.44, indicating it is 6.8% overvalued. The stock holds an Above Average GF Score™ of 78/100, driven by a strong Growth rank (10/10) but tempered by lower …